Hepatitis B virus (HBV) reactivation is a well-known complication related to immunosuppression. Clinical manifestations of HBV relapse range from self-limiting anicteric hepatitis to acute hepatic failure. Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma multiforme (GBM), the most common and deadliest of malignant primary brain tumors.
Glioblastoma multiforme and hepatitis B: do the right thing(s) / Purchiaroni, F; Begini, Paola; Minniti, G; Gallina, S; DELLE FAVE, Gianfranco; Marignani, M.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - STAMPA. - 18:23(2014), pp. 3629-3631.
Glioblastoma multiforme and hepatitis B: do the right thing(s)
BEGINI, PAOLA;Minniti, G;DELLE FAVE, Gianfranco;
2014
Abstract
Hepatitis B virus (HBV) reactivation is a well-known complication related to immunosuppression. Clinical manifestations of HBV relapse range from self-limiting anicteric hepatitis to acute hepatic failure. Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma multiforme (GBM), the most common and deadliest of malignant primary brain tumors.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
